Chloe Callahan brings a risk management perspective to pharmaceutical supply chains—one that has become increasingly central as supply chains face new forms of disruption.
As a Supply Chain Risk Management Specialist at Vertex Pharmaceuticals, she works on identifying, assessing, and mitigating vulnerabilities that could impact supply continuity.
Her work requires looking across geographies, across supplier tiers, and across different time horizons. It involves understanding not just immediate operational risks, but also longer-term structural vulnerabilities.
Today, these risks are shaped by a wider set of factors. Climate-related disruptions, geopolitical instability, and increasing expectations around transparency all play a role.
As a result, the boundaries between risk management and sustainability have started to blur. A supply chain that is resilient is increasingly also one that is diverse, responsibly sourced, and better understood.
Chloe’s work naturally sits at this intersection. It requires connecting risk visibility with broader questions of environmental and social responsibility.
At a company whose medicines have a direct impact on patient outcomes, the implications of supply chain failure are not abstract. That context brings clarity and urgency to the work she does.
Found her interesting? Connect with Chloe on LinkedIn.
